This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
All data generated or analyzed during this study are included in this published article [and its Supplementary Information files].
References
Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant. 2006;38:377–84.
Ramírez P, Brunstein CG, Miller B, Defor T, Weisdorf D. Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival. Bone Marrow Transplant. 2011;46:981–6.
Akahoshi Y, Kimura S, Gomyo A, Hayakawa J, Tamaki M, Harada N, et al. Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome. Hematol Oncol. 2018;36:276–84.
Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996;88:3223–9.
Bittencourt H, Rocha V, Chevret S, Socie G, Esperou H, Devergie A, et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;99:2726–33.
Ringdén O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol. 2003;121:874–5.
Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, et al. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood. 2003;102:3043–51.
Rocha V, Labopin M, Gluckman E, Powles R, Arcese W, Bacigalupo A, et al. Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. J Clin Oncol. 2002;20:4324–30.
Pichler H, Witt V, Winter E, Boztug H, Glogova E, Pötschger U, et al. No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation. Biol Blood Marrow Transpl. 2014;20:676–83.
Remberger M, Törlén J, Ringdén O, Engstroöm M, Watz E, Uhlin M, et al. Effect of Total Nucleated and CD34(+) cell dose on outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:889–93.
Acknowledgements
The authors thank Lina Alloush and Carlton Hughes from the human applications laboratory at St. Jude for assistance in collecting data.
Funding
This work was supported by NCI Cancer Center CORE Support Grant P30 CA 21765 and by ALSAC. JRW was supported by NCI Grant R25C0A23944.
Author information
Authors and Affiliations
Contributions
AS designed the study and wrote the manuscript. JRW and AYS collected the data and revised the manuscript. GK and YL performed the statistical analysis and revised the manuscript. SA and BT revised the manuscript and contributed to cell processing (SA) and patient management (BT).
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wells, J.R., Kang, G., Suliman, A.Y. et al. Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children. Bone Marrow Transplant 57, 1347–1349 (2022). https://doi.org/10.1038/s41409-022-01726-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-022-01726-2